David Lebwohl, EVP, Chief Medical Officer: Intellia Therapeutics NTLA Sell · Filed 25/01/07

Trade details

Type: Insider sale
Amount: $116,404.26
Shares · price: 9,557 sh · $12.18 a share
Held after: 87,666 sh
Stock: Intellia Therapeutics NTLA
Person: David LebwohlEVP, Chief Medical Officer
Trade date: 25/01/03
Filed: 25/01/07
Days to filing: 4 days

Sold 9.8% of holdings

Share of holding sold: 9.8%

Intellia Therapeutics trades, last 26 weeks

What else happened in Intellia Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/04~25/02/02

David Lebwohl's recent trades

David LebwohlEVP, Chief Medical Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$109.6K
11,903 sh
$109.6K
Filed 01/07
Traded 01/05
David LebwohlEVP, Chief Medical Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$172.1K
5,843 sh
$172.1K
Filed 24/01/05
Traded 24/01/03
David LebwohlEVP, Chief Medical Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$95.8K
2,574 sh
$95.8K
Filed 23/01/06
Traded 23/01/04